Morgan Stanley’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
1,362,176
-29,411
| -2% | -$280K | ﹤0.01% | 3204 |
|
|
2025
Q1 | $14.6M | Buy |
1,391,587
+637,994
| +85% | +$6.67M | ﹤0.01% | 3004 |
|
|
2024
Q4 | $17.8M | Sell |
753,593
-299,669
| -28% | -$7.06M | ﹤0.01% | 2876 |
|
|
2024
Q3 | $37.8M | Buy |
1,053,262
+494,210
| +88% | +$17.8M | ﹤0.01% | 2125 |
|
|
2024
Q2 | $19.7M | Sell |
559,052
-403,112
| -42% | -$14.2M | ﹤0.01% | 2687 |
|
|
2024
Q1 | $27.3M | Sell |
962,164
-3,080,626
| -76% | -$87.5M | ﹤0.01% | 2352 |
|
|
2023
Q4 | $53.8M | Buy |
4,042,790
+3,935,048
| +3,652% | +$52.3M | ﹤0.01% | 2371 |
|
|
2023
Q3 | $965K | Sell |
107,742
-7,103
| -6% | -$63.6K | ﹤0.01% | 4823 |
|
|
2023
Q2 | $1.29M | Buy |
114,845
+1,215
| +1% | +$13.7K | ﹤0.01% | 4675 |
|
|
2023
Q1 | $1.31M | Buy |
113,630
+49,200
| +76% | +$567K | ﹤0.01% | 4707 |
|
|
2022
Q4 | $747K | Sell |
64,430
-65,110
| -50% | -$755K | ﹤0.01% | 5030 |
|
|
2022
Q3 | $1.65M | Sell |
129,540
-98,510
| -43% | -$1.25M | ﹤0.01% | 4567 |
|
|
2022
Q2 | $1.57M | Sell |
228,050
-76,493
| -25% | -$526K | ﹤0.01% | 4707 |
|
|
2022
Q1 | $2.94M | Sell |
304,543
-69,377
| -19% | -$669K | ﹤0.01% | 4217 |
|
|
2021
Q4 | $4.45M | Buy |
373,920
+270,142
| +260% | +$3.21M | ﹤0.01% | 3843 |
|
|
2021
Q3 | $1.69M | Buy |
103,778
+99,122
| +2,129% | +$1.61M | ﹤0.01% | 4706 |
|
|
2021
Q2 | $98K | Buy |
4,656
+4,530
| +3,595% | +$95.3K | ﹤0.01% | 6367 |
|
|
2021
Q1 | $2K | Sell |
126
-24,149
| -99% | -$383K | ﹤0.01% | 7262 |
|
|
2020
Q4 | $510K | Buy |
+24,275
| New | +$510K | ﹤0.01% | 5067 |
|